Patent · US Active

Method for preparation of retinal ganglion cells

US10584314B2 · kind B2 · utility

1Cited by
0References
4Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 7, 2015
Grant dateMar 10, 2020
Priority date
Expiry dateDec 3, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An object of the present invention is to provide a method of inducing pluripotent stem cells to differentiate into clinically applicable retinal ganglion cells.The present invention provides a method for inducing pluripotent stem cells to differentiate into retinal ganglion cells that can be used for clinical application. Such method is a method for producing retinal ganglion cells with elongated axons comprising the following steps: (a) a step of inducing pluripotent stem cells to differentiate into retinal progenitor cells via floating culture; (b) a step of inducing the retinal progenitor cells obtained in step (a) to differentiate into retinal ganglion cells via floating culture; and (c) a step of allowing axons to elongate via adhesion culture of the retinal ganglion cells obtained in step (b).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.